标题：中心性浆液性脉络膜视网膜病变治疗研究进展

      作者：林晓珊 综述 秦波 审校    暨南大学第二临床医学院，广东 广州 510632

      卷次： 2020年31卷8期

      【摘要】 中心性浆液性脉络膜视网膜病变(CSC)是引起中年男性视力下降最常见的原因之一，急性CSC病程常呈自限性，通常不需要干预就能痊愈，但存在部分病例反复发作或迁延不愈，形成眼底解剖结构改变，导致视力障碍，因此需要积极干预。对于CSC的治疗方案目前仍然未达到共识，因此寻找安全有效的治疗方法成为研究热点。本文对CSC的临床治疗研究进展做一综述。
      【关键词】 中心性浆液性脉络膜视网膜病变；眼底病；治疗；研究进展；综述
      【中图分类号】 R774.1 【文献标识码】 A 【文章编号】 1003—6350（2020）08—1063—05

Progress in the treatment of central serous chorioretinopathy.
LIN Xiao-shan, QIN Bo. The Second Clinical College,Jinan University, Guangzhou 510632, Guangdong, CHINA【Abstract】 Central serous chorioretinopathy, commonly referred to as CSC, is one of the most common causesof vision loss in middle-aged men. Acute CSC is typically a self-limiting disease, and visual recovery usually occurswithout treatment. However, some cases have long course and recurrence, resulting in changes in the anatomical struc-ture of the fundus, which results in visual disturbance, so these cases require active intervention. There is still no consen-sus on the treatment of CSC, so as that the search for safe and effective treatment methods has become a research focus.This article reviews the progress of clinical treatment of CSC.
      【Key words】 Central serous chorioretinopathy (CSC); Fundus disease; Treatment; Research progress; Review·综述·doi:10.3969/j.issn.1003-6350.2020.08.032基金项目：广东省科技计划项目(编号：2017A020211028)；广东省深圳市科技计划项目(编号：JCYJ20180228164300106)